Comparing New-onset Diabetes in Post Moderate-to-severe Coronavirus Disease 2019 Patients with Newly Diagnosed Diabetes Patients with Mild or without Prior Coronavirus Disease 2019 Infection

• Principais autores: Rupak Chatterjee (Autor), Shatavisa Mukherjee (Autor), Supratik Bhattacharyya (Autor), Debasis Basu (Autor), Netai Pramanik (Autor)
• Formato: Livro
• Publicado em: Wolters Kluwer Medknow Publications, 2024-09-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Background: Systemic inflammation and various drugs used for treating coronavirus disease 2019 (COVID-19) including high-dose corticosteroids play a role in the development of new-onset diabetes (NOD). Patients of all ages and genders recovering from COVID-19 reportedly have an increased incidence a...